首页 | 本学科首页   官方微博 | 高级检索  
     

抗肿瘤坏死因子-α单克隆抗体治疗实验性自身免疫性葡萄膜视网膜炎的研究
引用本文:张锐,钱江,袁一飞. 抗肿瘤坏死因子-α单克隆抗体治疗实验性自身免疫性葡萄膜视网膜炎的研究[J]. 中华眼底病杂志, 2008, 24(5): 336-339
作者姓名:张锐  钱江  袁一飞
作者单位:复旦大学附属眼耳鼻喉医院眼科,上海,200031
摘    要:目的 观察抗肿瘤坏死因子-α单克隆抗体(TNF-α MCAb)对于实验性自身免疫性葡萄膜视网膜炎(EAU)的治疗作用。方法 合成光感受器间维生素A类结合蛋白(IRBP)R16多肽片段,联合免疫佐剂诱导EAU动物模型。按照注射次数不同将大鼠分为2组,分别于IRBP R16免疫后的第6天和第4、6、8天自大鼠尾静脉注入TNF-α MCAb,裂隙灯显微镜观察其眼部临床表现,同时设未治疗组大鼠作为对照。于IRBP R16免疫后第13天测量迟发型超敏反应(DTH),并于第14天处死大鼠,取眼球行组织病理检查。应用酶联免疫吸附试验(ELISA)检测抗体注射后14 d 时大鼠血清中Th1类细胞因子γ-干扰素(IFN-γ)、Th2类细胞因子白细胞介素-4(IL-4)水平以及房水中IFN-γ水平。测量引流淋巴结细胞的抗原特异性淋巴细胞增生反应。结果 TNF-αMCAb治疗组大鼠的眼部炎症较未治疗组明显减轻,病理分级下降;房水和血清中IFN-γ水平降低,血清中IL-4增高;DTH反应下降;引流淋巴结细胞对IRBP R16多肽刺激的增生反应下降,差异均有统计学意义(P<0.01)。与单次注射相比,3次注射的治疗效果更显著(P<0.05)。结论 TNF-αMCAb能够有效减轻EAU大鼠眼部的炎症反应和特异性细胞免疫反应,改变Th1/Th2细胞因子平衡;多次应用作用更显著。

关 键 词:葡萄膜炎/免疫学  视网膜炎/免疫学  肿瘤坏死因子α/投药和剂量  抗体,单克隆/投药和剂量  动物实验
收稿时间:2008-04-17

Treatment of experimental autoimmune uveoretinitis with anti-tumor necrosis factor-α monoclonal antibody
ZHANG Rui,QIAN Jiang,YUAN Yi-fei. Treatment of experimental autoimmune uveoretinitis with anti-tumor necrosis factor-α monoclonal antibody[J]. Chinese Journal of Ocular Fundus Diseases, 2008, 24(5): 336-339
Authors:ZHANG Rui  QIAN Jiang  YUAN Yi-fei
Affiliation:Department of Ophthalmology, Eye and ENT Hospital affiliated to Fudan University, Shanghai 200031, China Department of Ophthalmology, Eye and ENT Hospital affiliated to Fudan University, Shanghai 200031, China Department of Ophthalmology, Eye and ENT Hospital affiliated to Fudan University, Shanghai 200031, China
Abstract:Objective To observe the efficacy of the anti-tumor necrosis factor-α monoclonal antibody(TNF-α MCAb)in the treatment of experimental autoimmune uveoretinitis(EAU). Methods EAU animal models were induced by interphotoreceptor retinoid-binding protein(IRBP)R16 peptide with immunization.The rats were divided into 2 groups according to the injection times.TNF-α MCAh was administered intravenously on day 6 or 4,6 and 8 post-immunization respectively,and then to observe the clinical expression by slit-lamp microscope.Meanwhile,take the rats which did not accept TNF-α MCAb as conttol group.Delayed type hypersensitivity(DTH)responses were measured on day 13 postimmunization of IRBP R16;the rats were killed on day 14 post-immunization of IRBP R16,and then enucleated the eyes for histopathological examination.To detect the cytokine level of IFN-γ,IL-4 in serum and IFN-γ in aqueous humor by enzyme-liked immunosorbent assay(ELISA)on day 14 postinjection.The hyperplasia responses of antigen specific lymphocyte of draining lymph node cells were detected. Results The TNF-αMCAb group had mitigated ocular inflammation and decreased pathological grades compared with the control group;the IFN-γ concentrations in aqueous humor and serum were decreased,IL-4 was increased in serum;DTH responses were decreased;the hyperplasia responses of draining lymphocytes to IRBP R16 peptide were decreased,all the differences were statistically significant(P<0.01).The rats accepted TNF-α MCAb thrice had much better curative effect than the rats injected once(P<0.05). Conclusions Injection of TNF-α MCAb can inhibit ocular inflammation and specific immune cells of EAU remarkably and change the Th1/Th2 balance.Many times injections of TNF-α MCAb were more effective than once.
Keywords:Uveitis/immunology  Retinitis/immunology  Tumor necrosis factor-alpha/administration & dosage  Antibodies,monoclonal/administration & dosage  Animal experimentation
本文献已被 万方数据 等数据库收录!
点击此处可从《中华眼底病杂志》浏览原始摘要信息
点击此处可从《中华眼底病杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号